| Serial Number | 97132159 |
| Word Mark | K KNOA PHARMA |
| Filing Date | Thursday, November 18, 2021 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, October 7, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, May 2, 2023 |
| Description of Mark | The mark consists of a stylized letter K followed by the word KNOA in large, lower case letters above the word PHARMA in small, upper case letters. |
| Goods and Services | A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "PHARMA" |
| Goods and Services | Pharmaceutical research and development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 23, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 23, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Purdue Pharma L.P. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 13 - Limited Partnership |
| Address | Stamford, CT 06901 |
| Party Name | Purdue Pharma L.P. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 13 - Limited Partnership |
| Address | Stamford, CT 06901 |
| Event Date | Event Description |
| Monday, November 22, 2021 | NEW APPLICATION ENTERED |
| Tuesday, November 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 7, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, June 14, 2022 | PRIORITY ACTION WRITTEN |
| Tuesday, June 14, 2022 | PRIORITY ACTION E-MAILED |
| Tuesday, June 14, 2022 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, December 7, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 7, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 7, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 27, 2022 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 7, 2023 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, April 12, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 2, 2023 | PUBLISHED FOR OPPOSITION |
| Monday, March 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 2, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, June 1, 2023 | OPPOSITION INSTITUTED NO. 999999 |
| Thursday, June 1, 2023 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Friday, April 12, 2024 | OPPOSITION DISMISSED NO. 999999 |
| Friday, April 12, 2024 | TTAB RELEASE CASE TO TRADEMARKS |
| Friday, April 12, 2024 | OPPOSITION TERMINATED NO. 999999 |
| Monday, October 7, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, October 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 7, 2024 | SOU EXTENSION 1 GRANTED |
| Monday, October 7, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |